(AMENDMENT NO. 1)*

Company

KIORA PHARMACEUTICALS INC

Filed

February 13, 2023

Accession Number

0000929638-23-000423

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →